[OH:1][CH2:2][CH2:3][O:4][C:5]1[C:14]2[C:9](=[CH:10][CH:11]=[CH:12][CH:13]=2)[N:8]=[C:7]([N:15]2[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]2)[N:6]=1.[C:21]([OH:24])(=[O:23])[CH3:22]>CO>[C:21]([OH:24])(=[O:23])[CH3:22].[OH:1][CH2:2][CH2:3][O:4][C:5]1[C:14]2[C:9](=[CH:10][CH:11]=[CH:12][CH:13]=2)[N:8]=[C:7]([N:15]2[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]2)[N:6]=1To a solution of 4-[(2-hydroxyethyl)oxy]-2-(1-piperazinyl)quinazoline (cf. Example 42) (1.2 g) in methanol (20 ml) is added acetic acid (0.3 g), and the mixture is evaporated to dryness under reduced pressure. The residue is recrystallized from acetonitrile to give 4-[(2-hydroxyethyl)oxy]-2-(1-piperazinyl)quinazoline monoacetate (0.2 g) as crystals.
読み込み中…